Advertisement

Topics

What's Missing In Intellipharmaceutics' Opioid Filing? FDA Panel Offers List

15:02 EDT 30 Jul 2017 | SCRIP

Advisory committee notes missing pieces in sponsor's data for abuse-deterrent oxycodone extended release opioid; excipients to deter abuse also need...

      

Related Stories

 

Original Article: What's Missing In Intellipharmaceutics' Opioid Filing? FDA Panel Offers List

NEXT ARTICLE

More From BioPortfolio on "What's Missing In Intellipharmaceutics' Opioid Filing? FDA Panel Offers List"

Quick Search
Advertisement